EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic Cancer
NCT02209415
Interventional
Not Applicable
Unknown status
EUFURO
Follow-up after successful operative treatment of cancer in the esophagus, stomach or pancreas in order to detect recurrent disease is a controversial topic. This is because the methods and the consequence of following these patients is unknown. Therefore the investigators will randomize these patients in to two groups: One group of patients will be offered visits with a specialist surgeon in a outpatient setting for a clinical evaluation every 3,6,9,12,18 and 24 months after surgery, as is the current standard at our department.
The other group will be offered Endoscopic UltraSound, EUS, and PET/CT with the same intervals as the first group.
Apr 30,2011
All
18 Years
N/A
18 Years
N/A
182